---
title: "First patient enrolled in Concept Medical’s MAGICAL BTK IDE trial"
date: "2025-01-17T11:24:08.000Z"
publishedDate: "17 janvier 2025"
summary: "Concept Medical has successfully enrolled the first patient in the MAGICAL BTK US investigational device exemption (IDE) pivotal trial, a press release reveals. Following the recent IDE approval by the US Food and Drug Administration (FDA) for the MagicTouch PTA, this enrolment heralds the beginning of Concept Medical&#8216;s peripheral clinical trial programme in the USA."
importance: ""
sourceUrl: "https://vascularnews.com/first-patient-enrolled-in-concept-medicals-magical-btk-ide-trial/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2025-01-17-first-patient-enrolled-in-concept-medicals-magical-btk-ide-trial"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2025/01/Concept-Medical-logo-web.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/first-patient-enrolled-in-concept-medicals-magical-btk-ide-trial/"
---

![First patient enrolled in Concept Medical’s MAGICAL BTK IDE trial](https://vascularnews.com/wp-content/uploads/sites/7/2025/01/Concept-Medical-logo-web.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/first-patient-enrolled-in-concept-medicals-magical-btk-ide-trial/*

## L’essentiel

Concept Medical has successfully enrolled the first patient in the MAGICAL BTK US investigational device exemption (IDE) pivotal trial, a press release reveals. Following the recent IDE approval by the US Food and Drug Administration (FDA) for the MagicTouch PTA, this enrolment heralds the beginning of Concept Medical&#8216;s peripheral clinical trial programme in the USA.

## Lien source

https://vascularnews.com/first-patient-enrolled-in-concept-medicals-magical-btk-ide-trial/
